Published in J Urol on February 01, 1979
Some Observations on Chitin-destroying Bacteria. J Bacteriol (1932) 14.82
'Green revolution' genes encode mutant gibberellin response modulators. Nature (1999) 8.87
A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg (1988) 8.54
Studies of Freshwater Bacteria: II. Stalked Bacteria, a New Order of Schizomycetes. J Bacteriol (1935) 7.31
The Arabidopsis GAI gene defines a signaling pathway that negatively regulates gibberellin responses. Genes Dev (1997) 7.30
LNCaP model of human prostatic carcinoma. Cancer Res (1983) 7.23
Methane emissions from cattle. J Anim Sci (1995) 5.59
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun (1990) 4.94
Mechanism of insect resistance to the microbial insecticide Bacillus thuringiensis. Science (1990) 4.89
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol (1992) 4.79
Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrob Agents Chemother (1993) 4.76
Interpretation of Emergency Department radiographs: a comparison of emergency medicine physicians with radiologists, residents with faculty, and film with digital display. AJR Am J Roentgenol (2000) 4.13
Signalling by receptor tyrosine kinases. Annu Rev Biochem (1993) 4.11
Medical evaluation of internationally adopted children. N Engl J Med (1991) 3.84
Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science (1989) 3.83
Bilateral Adrenalectomy in Prostatic Cancer: Clinical Features and Urinary Excretion of 17-Ketosteroids and Estrogen. Ann Surg (1945) 3.65
Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A (2000) 3.44
Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer (1980) 3.37
Betaine improves the PCR amplification of GC-rich DNA sequences. Nucleic Acids Res (1997) 3.32
Purification of a human prostate specific antigen. Invest Urol (1979) 3.11
Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants. Ann Surg (1966) 3.06
The LNCaP cell line--a new model for studies on human prostatic carcinoma. Prog Clin Biol Res (1980) 2.97
Cancer of the breast: size of neoplasm and prognosis. Cancer (1969) 2.91
Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain. Mol Microbiol (1993) 2.80
Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. J Urol (1995) 2.80
New radiographic grading scales for osteoarthritis of the hand. Reliability for determining prevalence and progression. Arthritis Rheum (1989) 2.77
Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun (2001) 2.62
Carcinoembryonic antigen in patients with different cancers. JAMA (1972) 2.56
Predicting femoral neck strength from bone mineral data. A structural approach. Invest Radiol (1990) 2.55
Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci U S A (1991) 2.48
Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin (1993) 2.43
Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer (1991) 2.41
Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation. Ann Surg (1968) 2.29
Postoperative radiotherapy in the treatment of breast cancer: results of the NSABP clinical trial. Ann Surg (1970) 2.28
Metastases from transitional cell carcinoma of urinary bladder. Urology (1980) 2.24
Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol (2002) 2.18
Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet (1970) 2.17
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer (1998) 2.15
Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet (1983) 2.14
Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology (1990) 2.13
Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect Immun (1990) 2.12
Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood. Int J Cancer (1997) 2.11
The growing teratoma syndrome. Cancer (1982) 2.09
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). J Clin Oncol (2004) 2.07
Transthoracic needle aspiration biopsy of benign and malignant lung lesions. AJR Am J Roentgenol (1985) 2.05
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology (1998) 2.04
Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J Neurosci (2000) 2.03
American Joint Committee on Cancer prognostic factors consensus conference. Cancer (1999) 2.02
Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer. J Clin Oncol (1983) 2.01
Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia (2005) 1.99
Combat casualties in Northern Thailand: emphasis on land mine injuries and levels of amputation. Mil Med (1981) 1.94
Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg (1976) 1.92
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res (1988) 1.91
Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect Immun (1994) 1.91
Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases. Cancer (1987) 1.90
Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol (1998) 1.88
The association of body weight, body fatness and body fat distribution with osteoarthritis of the knee: data from the Baltimore Longitudinal Study of Aging. J Rheumatol (1995) 1.86
Association of radiographic features of osteoarthritis of the knee with knee pain: data from the Baltimore Longitudinal Study of Aging. Arthritis Care Res (1995) 1.85
Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res (1998) 1.83
Small cell carcinoma of the bladder and prostate. Urology (1995) 1.81
CT evaluation of amyloidosis: spectrum of disease. Radiographics (1993) 1.77
Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol (1992) 1.77
SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature (1971) 1.77
Race-related differences in breast cancer patients. Results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer (1985) 1.76
Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer (1981) 1.73
Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Infect Immun (1991) 1.72
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol (1995) 1.71
Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate (1999) 1.71
Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection. Infect Immun (1996) 1.69
Implication of cell kinetic changes during the progression of human prostatic cancer. Clin Cancer Res (1995) 1.68
Characterization of a new primary human pancreatic tumor line. Cancer Invest (1986) 1.67
Squamous cell carcinoma of renal pelvis. Urology (1985) 1.66
Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. J Urol (1987) 1.66
Hemolytic reaction of clinical and environmental strains of Vibrio vulnificus. J Clin Microbiol (1981) 1.62
Treatment of interstitial cystitis with intravesical heparin. Br J Urol (1994) 1.62
Coagulase-negative staphylococcal septicemia: experience in a newborn intensive care unit. J Pediatr (1982) 1.60
Carcinoembryonic antigen (CEA) in patients with carcinoma of the digestive tract. Ann Surg (1972) 1.59
Fibrin glue for partial nephrectomy. Urology (1991) 1.59
Quality of life of living kidney donors in Germany: a survey with the Validated Short Form-36 and Giessen Subjective Complaints List-24 questionnaires. Transplantation (2004) 1.59
Secondary carcinomas of the kidney. J Urol (1975) 1.59
The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer (1999) 1.58
Enlargement of the supraclavicular lymph nodes as the initial sign of prostatic carcinoma. Cancer (1971) 1.58
Clinical highlights from the National Cancer Data Base: 1994. CA Cancer J Clin (1994) 1.58
Successful living related kidney transplantation despite renal angiomyolipoma in situ. J Urol (1999) 1.57
Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J Clin Oncol (1991) 1.57
Transvascular flux and tissue accrual of Evans blue: effects of endotoxin and histamine. J Lab Clin Med (1988) 1.55
The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet (1984) 1.54
De novo muscle invasive bladder cancer: is there a change in trend? J Urol (2001) 1.54
Natural history of an adrenal myelolipoma. J Urol (1992) 1.53
Levels of platinum, palladium, and lead in populations of Southern California. Environ Health Perspect (1975) 1.53
Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J Neurosci (1999) 1.52
Sampling of radical prostatectomy specimens. How much is adequate? Am J Clin Pathol (1994) 1.51
Systemic candidiasis in very low-birth-weight infants (less than 1,500 grams). Pediatrics (1984) 1.51
In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection. Infect Immun (1998) 1.50
Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli. J Gen Microbiol (1992) 1.48